Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Auxly Cannabis Group Inc T.XLY

Alternate Symbol(s):  CBWTF

Healthcare
Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and... see more

TSX:XLY - Post Discussion

Auxly Cannabis Group Inc > Not sure
View:
Post by settoretire on Nov 09, 2024 12:20pm

Not sure

XLY  
Auxly Cannabis Group
XLY
 
Third quarter 2024 earnings released: EPS: CA$0.003 (vs CA$0.033 in 3Q 2023)
Third quarter 2024 results:
  • EPS: CA$0.003 (down from CA$0.033 in 3Q 2023).
  • Revenue: CA$33.3m (up 18% from 3Q 2023).
  • Net income: CA$3.24m (down 90% from 3Q 2023).
  • Profit margin: 9.7% (down from 116% in 3Q 2023).

Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Watchlist  
 
Be the first to comment on this post
Auxly Cannabis Group Inc